Mike Doustdar Novo Nordisk Novo Novo CEO
Pharma

Novo Nordisk’s ‘optimistic’ CEO Doustdar sits down with Fierce

Novo Nordisk CEO Mike Doustdar told Fierce in an interview that he always believed the Big Pharma “did actually need to become more competitive.”
Fraiser Kansteiner Jun 11, 2026 7:00am
ASCO 2026 showed that precision oncologys next challenge is translation

Precision oncology’s next challenge is translation

Brought to you by Thermo Fisher Scientific
Merck

Merck's Welireg expands in kidney cancer with adjuvant nod

Jun 15, 2026 11:46am
The legacy approach to real-world data is costing you

The legacy approach to real-world data is costing you

Brought to you by HealthVerity
medical professionals standing in a hallway at a hospital

IQVIA taps AI to put overlooked prescribers on marketers’ maps

Jun 15, 2026 11:44am
European Commission Approves CinnaGens Zandoriah teriparatide biosimilar for Osteoporosis in Adults

European Commission Approves CinnaGen’s Zandoriah (teriparatide)

Brought to you by CinnaGen
More News

After 2-month delay, Sanofi gains FDA expansion for Tzield

Jun 15, 2026 11:25am

Eisai gets UK backing as it expands plant for Leqembi production

Jun 15, 2026 10:20am

Lilly oncology chief ‘blown away’ by new Jaypirca CLL data

Jun 15, 2026 8:25am

EHA: J&J chalks up early-stage myeloma win for Talvey/Darzalex combo

Jun 13, 2026 6:00am